Module 1: (00:10:26-00:23:22) Welcome Note: Dr Ashutosh Gautam from Mankind Team welcomed all the participants and panelist and then he shared insights on how world is suffering from pandemic. He then shared the journey of Mankind pharma after that Dr Ashutosh introduced Dr. A.B. Singh, Secretary, (ICAAI), and handover the stage to Dr. Singh. Dr Singh then welcomed all the panelist and introduced ICAAI. Then Dr Gaur, president- ICAAI shared his thoughts about the event and then he introduced Dr Surya Kant and invited him as a guest of honor for the event
Module 2: (023:23- 0037:10) Inaugural Address: Dr. Surya Kant, MBBS, MD (Gold Medalist), Professor & Head, Dept. of Respiratory Medicine, King George’s Medical University, U.P., Lucknow, National Vice Chairman of IMA-AMS, started his speech by thanking panelist of ICAAI & giving homage to the doctors who lost their battle against COVID. Dr Surya Kant shared his experience working with ICAAI and how it benefits academically to healthcare profession.
Post that Dr Singh, introduced the 1st speaker Dr P.A. Mahesh and requested his to share his knowledge with the audience.
Module 3: (00:37:14-00:56:57) Managing Asthma: Current Guidelines and Updates: Dr. P.A. Mahesh, Professor, Pulmonary Medicine, JSSMC, JSSAHER, started his session by explaining about Asthma, its definition, personalized asthma management, he then shared about GINA 2019 explanation on fundamental change in asthma treatment. Dr Mahesh then shared the following points:
• Risk of mild asthma
• Risk of SABA on treatment
• Other changes in GINA 2021-mild asthma
• Proportion of adults having asthma
• LAMA
• Biologic therapy for severe type of asthma
• COVID-19 asthma & its treatment
• Deficiencies of GINA guidelines
• Disease progression
• Dose duration and asthma response to treatment
• Poor treatment outcomes
• Asthma prevention
Module 4: (00:59:00-01:17:22) Immunotherapy in Asthma and Allergic Rhinitis: Dr. S. N. Gaur, Professor, and Head, Dept. of Pulmonary Medicine at V. P. Chest Institute, University of Delhi, President ICAAI, continued the session. Dr Gaur explained in detailed about allergens, immunotherapy, asthma, management of allergen immunotherapy. He started his session by sharing the definition of the topi, principle of dosing, immunotherapy protocol. He briefly explained the following points:
• Allergy TH1 & TH2 cell therapy
• Mechanism of action of AIT
• Indication and contraindication of allergen immunotherapy
• Approach to administer immunotherapy
• Other routes of AIT
• Consideration for allergy practice due to COVID-19 pandemic
• Case presentation
• Summary
Module 5: (01:20:34-01:42:16) Managing Pulmonary Disorders: During COVID & Post COVID: Dr. Raj Kumar, MD (Pul. Med.), Director, VP Chest Institute, Delhi, Professor & HoD, Department of Pulmonary Medicine, Head, Pulmonary Medicine, Faculty of Medical Sciences, University of Delhi, Head, National Centre of Respiratory Allergy, Asthma & Immunology (NCRAAI) shared his immense knowledge and experience in managing pulmonary disorders during and post COVID. Dr Raj Kumar shared following points in brief during the session:
• AIIMs/ICMR guidelines for mild to moderate and severe disease
• Managing strategies for mild to moderate & severe disease
• Summary of ERS guidelines (for hospital COVID patients)
• Measures at CVCPI for COVID patient
• Post COVID management
Introduction
Post COVID symptom
Investigation
Management
Diet
Mental health
Vaccination
Pulmonary rehabilitation
Yoga
Conclusion
• Post COVID life style changes
Module 6: (01:43:22-01:56:14) Question and Answer: Several questions were asked during the event, which were asked by Dr Singh to all the speakers and at the session ended with a panel discussion.
Module 7: Vote of Thanks: Dr Ashutosh from Mankind Team & Dr. A.B. Singh & Dr Gaur from ICAAI shared vote of thanks with all and poll was raised.
Welcome Note: Mankind Team & Dr. A.B. Singh, Secretary, (ICAAI), Secretary-General, (SAAAACI), Scientist Emeritus (Ex) CSIR- Institute of Genomics and Integrative Biology (IGIB) Delhi University Campus ( 5 Mins )
Inaugural Address: Dr. Surya Kant, MBBS, MD (Gold Medalist), Professor & Head, Dept. of Respiratory Medicine, King George’s Medical University, U.P., Lucknow, National Vice Chairman of IMA-AMS ( 5 Mins )
Managing Asthma: Current Guidelines and Updates: Dr. P.A. Mahesh, Professor, Pulmonary Medicine, JSSMC, JSSAHER ( 20 Min )
Immunotherapy in Asthma and Allergic Rhinitis: Dr. S. N. Gaur, Professor, and Head, Dept. of Pulmonary Medicine at V. P. Chest Institute, University of Delhi, President ICAAI ( 20 Mins )
Managing Pulmonary Disorders: During COVID & Post COVID: Dr. Raj Kumar, MD (Pul. Med.), Director, VP Chest Institute, Delhi, Professor & HoD, Department of Pulmonary Medicine, Head, Pulmonary Medicine, Faculty of Medical Sciences, University of Delhi, Head, National Centre of Respiratory Allergy, Asthma & Immunology (NCRAAI) ( 20 Mins )
Question and Answer: Moderator: Dr. A.B. Singh, Secretary ICAAI ( 10 Mins )
Vote of Thanks: Mankind Team & Dr. A.B. Singh ( 5 Mins )
